XKRX
008490
Market cap168mUSD
Oct 08, Last price
20,250.00KRW
1D
-3.11%
1Q
2.27%
Jan 2017
-45.49%
Name
Suheung Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Suheung Co., Ltd. specializes in the production and provision of empty hard capsules, which are primarily utilized within the pharmaceutical and nutraceutical industries. The company further diversifies its business by offering comprehensive contract manufacturing services, accommodating a wide array of dosage types and packaging arrangements. Additionally, Suheung provides original equipment manufacturing (OEM) for paintball products. This South Korean firm, headquartered in Seoul, began its operations in 1973.
Key people
Geum Deok Park
President · since 2015
Tae Won Kim
Vice President · since 2019
Dae Mo Yang
Managing Director
Hong Guk Gwon
Assistant Managing Director
Bong Ho Jung
Assistant Managing Director
Jong Dae Kim
Assistant Managing Director
Sang Seon Kim
Assistant Managing Director · since 2022
Yeon Yil Kim
Assistant Managing Director
Eung Su Kim
Assistant Managing Director
Gang Hui Lee
Assistant Managing Director
Gwang Ho Lee
Internal Auditor · since 2023
Hyo Sik Yim
Assistant Managing Director
Jun Seong Yang
Managing Director · since 2022
Jun Taek Yang
Managing Director · since 2021
Ju Hwan Yang
Chairman, Chief Executive Officer · since 2010
Non-Executive Independent Director · since 2023
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||